Exelixis
EXEL
#1585
Rank
C$19.54 B
Marketcap
C$77.74
Share price
2.89%
Change (1 day)
30.12%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : C$0.93 Billion

According to Exelixis's latest financial reports the company's total liabilities are C$0.93 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exelixis - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$0.93 B-7.33%
2024-12-31C$1.00 B12.18%
2023-12-31C$0.89 B13.74%
2022-12-31C$0.79 B53.05%
2021-12-31C$0.51 B57.01%
2020-12-31C$0.32 B26.24%
2019-12-31C$0.26 B42.01%
2018-12-31C$0.18 B-60.55%
2017-12-31C$0.46 B-31.58%
2016-12-31C$0.68 B3.69%
2015-12-31C$0.65 B29.1%
2014-12-31C$0.50 B9.28%
2013-12-31C$0.46 B10.17%
2012-12-31C$0.42 B37.18%
2011-12-31C$0.30 B-47.73%
2010-12-31C$0.58 B10.36%
2009-12-31C$0.53 B-4.15%
2008-12-31C$0.55 B70.87%
2007-12-31C$0.32 B-8.19%
2006-12-31C$0.35 B10.68%
2005-12-31C$0.32 B10.93%
2004-12-31C$0.28 B13.51%
2003-12-31C$0.25 B-1.2%
2002-12-31C$0.25 B47.9%
2001-12-31C$0.17 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
C$169.91 B 18,096.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$166.37 B 17,717.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$118.25 B 12,564.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$90.16 B 9,555.83%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$117.46 B 12,479.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$94.21 B 9,989.61%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$85.42 B 9,049.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
C$60.08 M-93.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
C$0.10 B-89.00%๐Ÿ‡บ๐Ÿ‡ธ USA